Telomir Pharmaceuticals, Inc. Common Stock (TELO) — Financial Flexibility Index
Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a Financial Flexibility Index of -0.84x as of December 2025. Free cash flow of $-1.20 Million (operating CF $-1.20 Million minus capex $3.00) represents -1% of total liabilities ($1.43 Million). Also explore TELO shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Telomir Pharmaceuticals, Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Telomir Pharmaceuticals, Inc. Common Stock across 5 annual periods. See TELO equity financing ratio to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Telomir Pharmaceuticals, Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Telomir Pharmaceuticals, Inc. Common Stock. For the full company profile including market capitalisation, see TELO company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.58x | $-3.69 Million | $-3.69 Million | $1.43 Million | ▲ +65.3% |
| 2024 | -7.45x | $-5.07 Million | $-5.07 Million | $680.97K | ▼ -157.6% |
| 2023 | -2.89x | $-3.86 Million | $-3.86 Million | $1.34 Million | ▼ -508.0% |
| 2022 | -0.48x | $-468.66K | $-468.66K | $986.01K | ▲ +45.0% |
| 2021 | -0.86x | $-119.39K | $-119.40K | $138.13K | — |